OOS调查表
- 格式:pdf
- 大小:74.00 KB
- 文档页数:2
偏差处理(OOS)调查表偏差处理(OOS)调查表第 1 页共 3 页偏差处理(OOS)调查表表1OOS编号日期产品名称批号OOS项目检验方法标准/OOS结果是 ? 否计算结果是否已由第二人复核OOS结果是否由实验室差错产生(仪器错误数据、系统适应性未通过、是 ? 否标准品失效、试剂过期、样品使用错误、装置清洁未完全或不适当)是否已由本人进行复验:是否复验结果:检验人:复核人: QC负责人:偏差处理(OOS)调查表第 2 页共 3 页偏差(OOS)调查记录表2是否按取样程序取样是?否?无关样品是否混合均匀是?否?无关供试品是否有明显杂质或降解是?否?无关供试液是否正确稀释是?否?无关是否按检验SOP 检验是?否?无关所有计算是否已经过复核是?否?无关仪器是否在校正周期内是?否?无关操作环境是否符合规定是?否?无关基线是否正常(无噪音)是?否?无关峰分离度是否符合规定是?否?无关积分重现性是否符合规定是?否?无关色谱峰识别是否正确是?否?无关、溶剂是否影响主峰的积分是?否?无关光谱进样体积是否一致是?否?无关进样稳定是否一致是?否?无关积分方法是否一致是?否?无关所用试剂是否在有效期内是?否?无关试剂所用试剂是否正确储存是?否?无关、试剂取用量是否正确是?否?无关标准试液配制是否正确是?否?无关品标准品、对照品是否使用正确是?否?无关对照液是否正确稀释是?否?无关仪器的原始数据是否可接受是?否?无关检验人员是否经过培训是?否?无关是否存在相关的数据和记录是?否?无关是否需要复验:是否 QC负责人/批准人:复验结果:复验人:是否需要第二人复验:是否 QC负责人/批准人:复验结果:复验人:QA负责人偏差处理(OOS)调查表第 3 页共 3 页偏差(OOS)调查表3是否按取样程序取样是?否?无关原料CoA是否检查符合标准是?否?无关原料是否由合格供应商供应是?否?无关原料储存容器是否正常是?否?无关以下由产品或工艺相关人员完成生产设备是否存在异常情况或故障是?否?无关设备是否按程序清洗是?否?无关 QA是否批准设备的使用是?否?无关设备是否在校正期内是?否?无关设备是否有明显的污染是?否?无关工艺参数是否在规定范围内是?否?无关所有工艺计算是否核实是?否?无关是否使用正确的原料是?否?无关原料的批量是否核实是?否?无关生产过程是否存在失误操作是?否?无关生产环境是否存在偏差是?否?无关生产过程中是否存在不正常的监控记录是?否?无关其它可能的指示是?否?无关调查人:车间负责人:QC负责人: QA负责人:是否需要重新取样检验:是否 QC负责人/批准人:检验人:检验结果:准备6份新供试品平均:结果1:结果4:(供试液),以获得准确的测试结果结果2:结果5:标准偏差(?3%):结果3:结果6:检验人:复核人:QC负责人 QA负责人审核QC 车间QA 生产技术部物控部质量部注:本表用于偏差处理调查记录,不涉及的项目可不填写。
化验室不合格结果调查通知表01-017-04B化验室调查评估情况检查表01-017-04C调查产品调查日期调查批号生产日期调查原因调查人审核人批准人页码类别#检查项目观察结果分析设备/仪器1所用设备功能正常□ 是 □否2所用设备没受污染□ 是 □否3仪器已校正并处校验期内□ 是 □否4所有的仪器设备均正确使用□ 是 □否方法/操作规程5计算正确□ 是 □否6所用方法正确□ 是 □否7遵循正确的操作规程□ 是 □否8没有仪器问题□ 是 □否无证据表明标准品和样品降□ 是 □标准品/样品9解(样品制备前后)否10标准品和样品的称量、配制和稀释正确□ 是 □否11标准样品、试剂有标签□ 是 □否12各溶液在有效期内使用,贮存完好□ 是 □否样品制备13所用的试剂、溶剂、标准品、玻璃器皿或其它没被污染□ 是 □否14样品按方法正确制备□ 是 □否15所用的试剂、仪器、设备均正确使用□ 是 □否历史情况16过去对于这个产品有相似的情况出现□ 是 □否17过去出现过相似的错误□ 是 □否其他18环境条件适当□ 是 □否19分析规程和化验室操作一样□ 是 □否20在分析前后和分析过程中有异常现象出现□ 是 □否21化验中的所有记录文件都完备和正确□ 是 □否附加检查项目22重新测定□ 是 □否23重新取样□ 是 □否化验室不合格结果调查评估报告。
异常数据调查表编号:R-QC-003版本号:01 OOS编号:I.产品一般信息II.调查: QC组长及分析员应一起填写下表(所有内容均应填写)是否发现原因?或者是否有理论上的假设原因?如果是, 请详细说明如下:III.找到原因:如何证明此原因会产生错误的测试结果?是否需要重新测试:QC组长必须审批所有的重新测试重新测试审批签字: 日期: IV.未找到原因如果实验室未找到原因, QC组长应通知质管部部长或其代表质量系统总组长签字: 日期: (此签字代表正式承认OOS未找实验室原因)如果必要, 可以进行重新测试, 质量系负责人及QC组长必须批准此重新测试. QC组长签字: 日期:质管部部长签字: 日期:(此签字授权进行重新测试)V.重新测试详细说明重新测试是如何进行的:包括分析员, 所用的样品, 所用的设备, 是否需要制备新的标准样等.重新测试的结果如何?质量控制是否需要改进措施:(如果重新培训是改进措施, 将培训签字表附上)调查实施人签字: 日期:VI.生产过程调查:如果实验室找不到原因, 生产部部长必须对生产过程进行调查,生产此批产品时, 生产过程是否有问题?此生产过程的问题是否会造成OOS?是否对此生产过程的问题进行了调查研究? 此研究是否能证明此问题确实可以导致OOS.(将新做研究附上)如果确实由于生产过程的问题导致OOS, 有没有改进措施以防止同样的问题重复出现? (将有关的文件附上)此生产问题是否影响其他产品? 哪些产品受影响?列出所有受影响的产品批号, 说明所采取的措施以便确保这些产品的质量没有问题(附上所有相关的支持性文件)调查实施人签字: 日期:VII.质监部门调查结束后, 将所有的报告交给质管部部长或其代表.如何处置此批产品?调查表的审核及批准:质管部部长或其代表签字: 日期: QC组长签字: 日期。
图谱异常情况(00S情况)调查记录表
编号:R030001-00 制定依据:QB.WS.SOP030001
编号:R030002-01 制定依据:QB.WS.SOP030001
化验室调查
□已确认OOS发生原因(见附件)
□未确认OOS发生原因(见附件)
□防止再次发生的纠正措施(见附件)
QC审核人:日期:
QA审核人:日期:
批准人(QC负责人):日期:
附件:
需要附加的资料:所有的原始记录、重新化验的记录,以及负责整改的措施的人员等。
――常规调查记录表
注:按照调查的内容,在[是][否]上打“V”,如果打“V”请在备注中简要说明, 必要时附表。
如果此项内容不在调查范围,可在[N/A](表示不适用)上“V” 。
检测记录
编号R031319-00 制定依据:QB.WS.SOP030001 检品名称:检品批号:
检验日期:检验标准:
检验说明:
检验方法及检验结果:
00S化验室调查评估表
编号:R030003-01 制定依据:QB.WS.S0P030001。
OOS或问题结果调查记录表
1、调查原因:□超出规定范围□异常结果
实验项目:检验人:检验日期:
规定值:检验结果:
2、物料名称:批号:检验编号:
一、明显原因记录
1、明显原因:计算错误□稀释倍数错误□用错公式□单位换算错误□其它□
处理结果:解决问题,OOS无效□没有明显原因,开展检验室调查□
二、检验实调查记录
4、调查结果
□实验室样品的问题□检验偏差
□不能排除检验的偏差□类似问题曾经出现,且已得出调查结果的
调查人:_________________________ 调查日期:
5、采取措施
□原样品复验□不再进行复验□重新取样(同批次)检验
批准人:批准日期:
6、复检结果:
复检人:复检日期:
7、结论:
批准人:批准日期:
三、偏差调查报告
1、物料名称:数量:
批号:检验编号:
样品来源:________________________________________________________ ______
2、实验室调查报告编号:_______________________________________
3、信息回顾和评价
3.1 生产过程
3.2 待检物料的生产历史
3.3 工艺过程检验结果
3.4 待检物料其它项目检验结果
3.5 物料检验历史
3.6 从供应商处获得信息
4、是否需要重检□是□否
4.1重检目的:
4.2重检方案:
批准人:批准日期:
4.3重检结果:
5、调查结论:
QA:日期:
6、最后决定□进行事故调查□批准放行
质量部负责人:批准日期:。
图谱异常情况(OOS情况)调查记录表
编号:R030002-01 制定依据:QB.WS.SOP030001
化验室调查
□ 已确认OOS 发生原因(见附件) □ 未确认OOS 发生原因(见附件) □ 防止再次发生的纠正措施(见附件)
QC 审核人 :
日期: QA 审核人 : 日期: 批准人(QC 负责人): 日期: 附件:
需要附加的资料:所有的原始记录、重新化验的记录,以及负责整改的措施的人员等。
注:按照调查的内容,在[是] [否]上打“√”,如果打“√”请在备注中简要说明,必要时附表。
如果此项内容不在调查范围,可在[N/A](表示不适用)上“√”。
检测记录
编号R031319-00 制定依据:QB.WS.SOP030001 检品名称:检品批号:
检验日期:检验标准:
检验说明:
检验方法及检验结果:
检验人:复核人:
OOS化验室调查评估表
. '.。
OOS Documentation Form for OOS SOPThis investigation must be completed within twenty (20) business days of its inception or aDeviation Report must be filed for an extension.OOS #:Date:Product Name: Product Code #:Batch #: QC Control #: Test method:Specification: OOS Result:A) Initial Investigation – the original analyst will have a second analyst or chemist check all calculationsand notebook transcriptions for errors. This possible OOS occurrence must be reported to thesupervisor within one (1) business day.Yes – if the mistake was found, make the necessary corrections. This is not an OOS result buta QA Deviation Report must be completed and attached to this form. Was the error found? (Circle answer)No – proceed to step BAnalyst: Signature: Date: SecondAnalyst:Signature: Date: B) Second Investigation – did the apparent OOS result occur from a Conclusive Laboratory Error (incorrectdata resulting from instrument malfunction, failed system suitability, incorrect standards, expiredreagents, incorrect sample used, inadequate equipment cleaning, etc)?Yes – this data is saved but not reported, the instrument repaired, re-calibrated or the analyst re-trained. The analysis should be repeated on the original sample. This is not an OOS result but aQA Deviation Report must be completed and attached to this form. If the original sample is not available, a new sample is obtained and that procedure is documented. A ConclusiveLaboratory Error was found?(Circle answer)No – proceed to step C.Analyst: Signature: Date: SecondAnalyst:Signature: Date: C) OOS Investigation (part 1) – This is an OOS result and the directors of QA and Operations must benotified that a formal OOS Investigation has begun. The Heads of QC, QA and production or a processrelevant chemist will conduct the OOS Investigation; it should examine the following items, as aminimum.The Head of QC or designee must complete the following questionsWas the sampling procedure done properly? Yes No Was the original sample homogenesis? Yes No Was the analytical test method followed properly? Yes No Are all the calculations done properly? Were they re-checked? Yes No Was the instrument properly calibrated? Yes No Were there chromatographic problems, such as a) Normal/expected baseline (not noisy), b) Normal/expected peak resolution, c) Normal/expected integration reproducibility, d) Normal/expected reproducible and identified peaks, e) No evidence of contamination that could affected peak integration, f) Same injection volumes, g) Same temperatures, h) Same integration? Yes Yes Yes Yes Yes Yes Yes Yes No No No No No No No No Was the relevant notebook data and entries reviewed and found to correct? Yes No Were the proper reagents, standards or other solutions used? a) Within expiry, b) Was the correct dilution used, c) No evidence of reagent contamination or degradation? Yes Yes Yes Yes No No No No Was the previous result from this instrument acceptable? Yes NoQuality Assurance must complete the following questionsWas the sampling procedure done properly? Yes No For Raw Materials: was the supplier’s CoA checked, was the material approved for use? Yes No Was the container inspected (it was not damaged, there was no indication of contamination)? Yes NoProduction or a process relevant chemist must complete the following questionsWere the production records checked for process deviations and none found? a) Was the proper production equipment used, b) Was this equipment cleaned and released prior to use by QA, c) Was the equipment properly calibrated, d) No evidence of equipment contamination, e) Were all process parameters within the specified ranges, f) No evidence of operator error (bumping during a distillation, spillage), g) No unusual observations noted during the batch, h) Were all process calculations verified, i) Were the correct raw materials used and lot numbers confirmed? Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No No No No No No No No No NoAnother possibility - indicate Yes NoNo – this may be the assignable cause. If a QA or production error, complete a QA Deviation Report and attach a copy to this form. If a QC error, make the correction and repeat the analysis on the original sample. Re-sampling is permitted if the OOS result was caused by the sampling procedure itself or if the sample was shown to be unrepresentative. Complete a QA Deviation Report and attach a copy to this form.Were any of theanswers(Circle answer)Yes to all – the OOS is still undetermined, proceed to D. If the original sample is not available, anew sample is obtained and that procedure is documented.Analyst: Signature: Date: SecondAnalyst:Signature: Date: QA:Signature: Date: Production: Signature: Date:D) OOS Investigation (part 2) – A second analyst will test the original sample. If none is available, a new sample is obtained and that procedure is documented (re-sampling is not permitted unless the original is completelydepleted). Original value: 5th retest:1st retest: 6th retest: 2nd retest: 7th retest: 3rd retest Average of retests: Prepare seven (7) new test samples (solutions) to determine seven new reportable values (more samples may be tested at thediscretion of the Head of QC) to obtain a statistically significant result.4th retest: Standard Deviation (+/- 3%): Acceptable : all test results are within specifications, report these results and use to dispositionthe batch. Complete a QA Deviation Report and attach a copy to this form. The new, averaged valued is:(Circle answer) Unacceptable : if any single test result fails a specification, reject the batch, complete a QADeviation Report and attach a copy to this form.Analyst: Signature: Date: SecondAnalyst:Signature: Date: Director QA: Signature: Date: DirectorOperations: Signature: Date:。